Insightec announced today that it received additional FDA approval for treating essential tremor with its Exablate Neuro platform. Essential tremor commonly affects both sides of the body, Insightec noted in a news release. The new approval allows appropriate patients to receive treatment on their second side at least nine months after treatment of the first side.
ET Conference Sessions are Now Available on YouTube; Consider a Year-End Gift to the IETF; Listen to Our Latest Podcast; Clinical Trials Need You!
Research shows that one of every 100 people on the planet has essential tremor (ET). This is one of the many results published in the article, “How Common is Essential Tremor? Update on the Worldwide Prevalence of Essential Tremor.” Learn more statistics in this podcast interview with co-author of the study, Dr. Elan Louis, professor […]